Ratings by Nephron
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/23/2026 | Chris Pasquale | Boston Scientific | BSX | Upgrade | Buy (Hold) |
N/A (N/A) |
64.87 (45.60) |
-29.71% | Details |
| 4/20/2026 | Eric P | Humana | HUM | New Coverage | Hold (N/A) |
200.00 (N/A) |
205.14 (359.13) |
75.07% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 79 more... | |||||||||
